IRIS Accounts Production v24.3.2.46 11549430 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false A Ordinary 1.00000 B Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh115494302023-09-30115494302024-09-30115494302023-10-012024-09-30115494302022-09-30115494302022-10-012023-09-30115494302023-09-3011549430ns15:EnglandWales2023-10-012024-09-3011549430ns14:PoundSterling2023-10-012024-09-3011549430ns10:Director12023-10-012024-09-3011549430ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3011549430ns10:SmallEntities2023-10-012024-09-3011549430ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3011549430ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3011549430ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3011549430ns10:FullAccounts2023-10-012024-09-3011549430ns10:OrdinaryShareClass12023-10-012024-09-3011549430ns10:OrdinaryShareClass22023-10-012024-09-3011549430ns5:CurrentFinancialInstruments2024-09-3011549430ns5:CurrentFinancialInstruments2023-09-3011549430ns5:ShareCapital2024-09-3011549430ns5:ShareCapital2023-09-3011549430ns5:FurtherSpecificReserve3ComponentTotalEquity2024-09-3011549430ns5:FurtherSpecificReserve3ComponentTotalEquity2023-09-3011549430ns5:RetainedEarningsAccumulatedLosses2024-09-3011549430ns5:RetainedEarningsAccumulatedLosses2023-09-3011549430ns10:RegisteredOffice2023-10-012024-09-3011549430ns5:MotorVehicles2023-10-012024-09-3011549430ns5:ComputerEquipment2023-10-012024-09-3011549430ns5:MotorVehicles2023-09-3011549430ns5:ComputerEquipment2023-09-3011549430ns5:MotorVehicles2024-09-3011549430ns5:ComputerEquipment2024-09-3011549430ns5:MotorVehicles2023-09-3011549430ns5:ComputerEquipment2023-09-3011549430ns5:CostValuation2023-09-3011549430ns5:RevaluationsIncreaseDecreaseInInvestments2024-09-3011549430ns5:CostValuation2024-09-3011549430ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3011549430ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3011549430ns5:DeferredTaxation2023-10-012024-09-3011549430ns5:DeferredTaxation2024-09-3011549430ns10:OrdinaryShareClass12024-09-3011549430ns10:OrdinaryShareClass22024-09-30
REGISTERED NUMBER: 11549430 (England and Wales)













Unaudited Financial Statements

for the Year Ended 30 September 2024

for

LRH BREAST SURGERY LIMITED

LRH BREAST SURGERY LIMITED (REGISTERED NUMBER: 11549430)






Contents of the Financial Statements
FOR THE YEAR ENDED 30 SEPTEMBER 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


LRH BREAST SURGERY LIMITED (REGISTERED NUMBER: 11549430)

Balance Sheet
30 SEPTEMBER 2024

30.9.24 30.9.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 64,436 84,370
Investments 5 108,224 93,996
172,660 178,366

CURRENT ASSETS
Debtors 6 6,450 6,424
Cash at bank 398,551 296,546
405,001 302,970
CREDITORS
Amounts falling due within one year 7 108,420 72,168
NET CURRENT ASSETS 296,581 230,802
TOTAL ASSETS LESS CURRENT
LIABILITIES

469,241

409,168

PROVISIONS FOR LIABILITIES 8 18,165 -
NET ASSETS 451,076 409,168

CAPITAL AND RESERVES
Called up share capital 9 20 20
Fair value reserve 10 6,168 -
Retained earnings 444,888 409,148
SHAREHOLDERS' FUNDS 451,076 409,168

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 January 2025 and were signed on its behalf by:





L R Owen - Director


LRH BREAST SURGERY LIMITED (REGISTERED NUMBER: 11549430)

Notes to the Financial Statements
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

LRH Breast Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11549430

Registered office: 1st Floor Waterside House
Waterside Drive
Wigan
Lancashire
WN3 5AZ

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Motor vehicles - 25% on reducing balance
Computer equipment - 25% straight line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

LRH BREAST SURGERY LIMITED (REGISTERED NUMBER: 11549430)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 October 2023 117,480 6,010 123,490
Additions - 1,639 1,639
At 30 September 2024 117,480 7,649 125,129
DEPRECIATION
At 1 October 2023 36,661 2,459 39,120
Charge for year 20,205 1,368 21,573
At 30 September 2024 56,866 3,827 60,693
NET BOOK VALUE
At 30 September 2024 60,614 3,822 64,436
At 30 September 2023 80,819 3,551 84,370

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 October 2023 93,996
Revaluations 14,228
At 30 September 2024 108,224
NET BOOK VALUE
At 30 September 2024 108,224
At 30 September 2023 93,996

Cost or valuation at 30 September 2024 is represented by:

Other
investments
£   
Valuation in 2022 (8,303 )
Valuation in 2023 2,299
Valuation in 2024 14,228
Cost 100,000
108,224

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Other debtors 6,450 6,424

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£    £   
Taxation and social security 76,560 69,872
Other creditors 31,860 2,296
108,420 72,168

LRH BREAST SURGERY LIMITED (REGISTERED NUMBER: 11549430)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024

8. PROVISIONS FOR LIABILITIES
30.9.24 30.9.23
£    £   
Deferred tax 18,165 -

Deferred
tax
£   
Provided during year 18,165
Balance at 30 September 2024 18,165

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £    £   
19 A Ordinary 1 19 19
1 B Ordinary 1 1 1
20 20

10. RESERVES
Fair
value
reserve
£   
Fair Value Transfer 8,224
Tax on Fair Value Movement (2,056 )

At 30 September 2024 6,168